Home
Wearable Injectors and Connected Devices USA
September 8 - September 9, 2025
Wearable Injectors and Connected Devices USA

Engage in the Latest Innovations and Developments in Wearable Injectors and Connected Devices This September in Boston!

SAE Media Group’s 3rd Annual Wearable Injectors and Connected Devices USA Conference will return to Boston for 2025 on the 8th and 9th of September, bringing you the latest advances in connected on body drug delivery.

Join leading experts from the injectable drug delivery and digital health sectors for a two-day exploration of the latest advancements in the field. Dive into sessions on large-volume drug delivery technologies, digital integration, and user-centric design, featuring expert insights, real-world case studies, and opportunities for collaboration.

As part of SAE Media Group’s leading Injectable series of conferences, we bring together high-level experts from big pharma and device developers to network and share knowledge to advance R&D. The two-day conference will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry.

Make sure you don’t miss out by attending this event in September 2025!
 

FEATURED SPEAKERS

Anjana Wills

Anjana Wills

Head of Device Combination Products and Software Quality, AstraZeneca
Cheng Yang

Cheng Yang

Digital Diagnostics Lead, Drug Product and Device Development, R&D, Takeda
Cindy Tritton

Cindy Tritton

Project Lead, Senior Engineer III, Technical Development , Biogen
Dan Jeffrey

Dan Jeffrey

Director of Sales - Medical, Lohmann Corporation
Deep Bhattacharya

Deep Bhattacharya

Principal Scientist Formulation and Process Development - Biotherapeutics, Pfizer
Ellie Younger

Ellie Younger

Global Technical Operations, AstraZeneca
George Currier

George Currier

Senior Principal Scientist, Device Development, Bristol Myers Squibb
Harry Jiang

Harry Jiang

Device Engineering Lead, Alexion Pharmaceuticals
Jia Huang

Jia Huang

Associate Director, Merck & Co.
Khaudeja Bano

Khaudeja Bano

Vice President - Global Head of Device Quality, Roche-Genentech
Mark Harycki

Mark Harycki

Senior Director, Device Portfolio and Program Management, Eli Lilly and Company
Michael Price

Michael Price

Associate Director, Human Factors, AstraZeneca
Paul Upham

Paul Upham

Global Head of Smart Devices, Roche-Genentech
Prasad Peri

Prasad Peri

AVP Regulatory Affairs Connected Delivery, Devices and Digital Health, Eli Lilly
Ravi Kaushik

Ravi Kaushik

Vice President, Global Head of Device & Digital Innovation & Prod Strategy, Plasma Derived Therapies, Takeda Pharmaceuticals
Sriram Natarjaan

Sriram Natarjaan

Sr. Manager, Product Quality Management, Johnson & Johnson
Yvette Appleby

Yvette Appleby

Senior Manager, Digital Health & PMO, Pfizer

Anjana Wills

Head of Device Combination Products and Software Quality, AstraZeneca
Anjana Wills

Anjana Wills is a senior quality and regulatory leader with over two decades of experience in medical devices, biologics, and combination products. She is currently the Head of Device, Combination Products, and Software Quality at AstraZeneca, where she provides strategic oversight of global quality systems, regulatory compliance, and product development. Previously, she served as Global Head of Quality for Devices and Combination Products at Biogen, leading worldwide quality operations across design, development, manufacturing, and post-market management. During her 11 years at Biogen, she also held leadership roles including Associate Director, Device and Clinical L/P, Principal Design Engineer, and Senior Manager, Product Quality. Her career began at Becton Dickinson (BD), where she spent nearly 14 years as a Senior Quality Engineer, developing deep expertise in quality engineering, product design transfer, and regulatory strategy. Anjana brings expert knowledge in device and combination product design, validation, continuous improvement, and global regulatory submissions, with direct experience working with the FDA and EMA. She is ASQ CQE certified and a Master Black Belt in Design for Six Sigma, recognized for leading continuous improvement initiatives and advancing patient-focused innovations in drug delivery.

Cheng Yang

Digital Diagnostics Lead, Drug Product and Device Development, R&D, Takeda
Cheng Yang

Dr. Cheng Yang is the Digital Diagnostics Lead at Takeda’s Global R&D organization, based in Boston. He leads the global strategy and development of digital diagnostic devices and AI/ML-enabled software for disease diagnosis, screening, and treatment monitoring. Holding a Ph.D. in Analytical Chemistry and a Master’s in AI/ML, Dr. Yang has driven cross-functional initiatives linking diagnostics with therapeutic products. His work includes point-of-care tools, companion diagnostics, and AI-powered imaging and screening solutions. He also represents Takeda in the EU IHI-funded SEARCH consortium, advancing the use of synthetic health data to support the development and deployment of next-generation e-health solutions.

Cindy Tritton

Project Lead, Senior Engineer III, Technical Development , Biogen
Cindy Tritton

Dan Jeffrey

Director of Sales - Medical, Lohmann Corporation
Dan Jeffrey

Dan has been at Lohmann since June 2024.  Prior to this role, he held various R&D, Technical, Operations and Business Leadership positions with increasing responsibility at Scapa, Hydrofera/Hollister and Momentive. The majority of his career has been spent in developing, and marketing pressure sensitive adhesive products in the medical, automotive and industrial markets, working closely with customers to match their application needs.  Born and raised in the NW of England, Dan has associate degrees in Chemistry, Business and Finance and a High Honours Degree in Polymer Science and Technology from The Manchester Metropolitan University in the UK.

Deep Bhattacharya

Principal Scientist Formulation and Process Development - Biotherapeutics, Pfizer
Deep Bhattacharya

Deep is an ambitious results-oriented CMC drug product pharmaceutical professional, currently working as Principal Scientist Formulation and Process Development at Pfizer. He has 6+ experience in formulation/biopharmaceutical sciences (mAbs, fusion proteins, recombinant proteins, mRNA modalities), and product development, resulting in multiple regulatory submissions (IND and BLAs) and cross-functional collaborations across the organization.

Ellie Younger

Global Technical Operations, AstraZeneca
Ellie Younger

Ellie Younger is Assoc Principal Engineer at AstraZeneca.  She oversees technical aspects of commercially launched combination products including management of the design history file, ongoing risk management activities, design transfer to new manufacturing sites and design changes.  Ellie has a BS in Biomedical Engineering from the Milwaukee School of Engineering, a MS in Human Factors Engineering from Wright State University and a MS in Engineering Management from Tufts University.

George Currier

Senior Principal Scientist, Device Development, Bristol Myers Squibb
George Currier

George is a Senior Principal Scientist in the Device Development group at Bristol Myers Squibb. He holds a Master of Science degree in Mechanical Engineering from Stevens Institute of Technology. Over the past 11 years at BMS, George has held roles in product strategy, as well as combination product development. He has led device innovation initiatives with development partners and has served as the Device Development lead for combination product development programs.

Harry Jiang

Device Engineering Lead, Alexion Pharmaceuticals
Harry Jiang

Harry obtained a Master of Science degree in Chemical Engineering from the University of Maine at Orono. His medical device career started at Bayer Healthcare Diabetes care division in Indiana 20 years age. After seven plus years at Bayer, Harry moved to the Boston area and continued working in the medical device and diagnostic industries including an OBI startup. He is currently with Alexion Pharmaceuticals, a AZ rare disease unit as a device engineering lead working on drug and device combination products.

Jia Huang

Associate Director, Merck & Co.
Jia Huang

With 18 years of extensive experience in the pharmaceutical and medical device industries, Dr. Jia Huang serves as an Associate Director at Merck & Co., a global leader in delivering innovative medical solutions to improve patient health worldwide.
Dr. Huang specializes in developing and implementing global regulatory strategies for digital health technologies used in clinical investigations, including Software as a Medical Device, software in medical devices, artificial intelligence, and machine learning applications. Passionate about advancing regulatory science, she actively collaborates with cross-functional teams and external partners to address emerging challenges and achieve shared goals in the ever-evolving healthcare landscape.
 

Khaudeja Bano

Vice President - Global Head of Device Quality, Roche-Genentech
Khaudeja Bano

Khaudeja is a Physician with a Masters in Clinical Research, Pharmaceutical engineering Certification, a Database Administrator and a certified Project Management Professional.
 

Khaudeja has more than 25 years’ professional experience, including clinical practice. She has held several global medical positions at Guidant, Abbott, AbbVie Inc and Amgen. Her career includes global medical / clinical
and safety leadership roles in devices, diagnostics, pharmaceuticals and combination products.


She currently serves as the chair for the Post Marketing Safety working group for the Combination Product Coalition (CPC).

Mark Harycki

Senior Director, Device Portfolio and Program Management, Eli Lilly and Company
Mark Harycki

Mark W. Harycki is a seasoned professional with expertise in pharmaceutical and medical device development. He has a strong background in clinical trials, dry product processing, parenteral processing, device assembly, packaging, and distribution. Mark specializes in a wide range of medical devices, including insulin pens, auto injectors, large volume injectors and stents. He has served as a senior advisor, overseeing device development programs from inception to submission approval. His expertise spans lean manufacturing, project oversight, budgetary planning, quality system auditing, process development, supplier management, and product line transfers. Currently, Mark is a Senior Director, Device Portfolio and Program Management, in Device and Connected Solutions at Eli Lilly and Company. He has led various submissions and approvals, including dry products, oral suspension, insulin pens, and immunology devices.


 

Michael Price

Associate Director, Human Factors, AstraZeneca
Michael Price

Mike is an Associate Director of Human Factors at AstraZeneca where he is responsible for creating HFE strategies for non-platform delivery systems. Prior to AstraZeneca he held multiple roles at Biogen in both Quality and Development where he supported the design and development of classic drug delivery platforms such as prefilled syringes and autoinjectors as well as on-body injectors, implantable devices, and digital diagnostic tools contributing to several market authorization applications.

Paul Upham

Global Head of Smart Devices, Roche-Genentech
Paul Upham

Paul is the Global Head of Smart Devices at Roche / Genentech. Paul has 20+ years of experience in medical device R&D, strategic marketing, product management, clinical research, and medical informatics.
Prior to Roche / Genentech, Paul was with Becton Dickinson(BD), as Worldwide Director of Strategic Marketing in their Pharmaceutical Systems business.

Paul was also the head of Product at WellDoc, Inc., where he led the product management activities for WellDoc’s portfolio of mobile health solutions. He was responsible for WellDoc’s landmark BlueStar™ product, a class II medical device and the world’s first reimbursed, prescription-only software for diabetes.

Paul’s prior experience includes 10 years in BD’s Diabetes Care business. Paul was responsible for the award-winning BD InterActiv® Diabetes Software, and was a member of the BD / Medtronic team that launched ParadigmLink®, the world’s first wireless blood glucose meter.

Paul holds four issued patents in medical software and drug delivery devices and has multiple patent applications. He is also an author of numerous peer-reviewed articles in medical informatics and diabetes. His education includes undergraduate studies in cognitive science and graduate work in health informatics and finance at the University of Minnesota and New York University.

 

Prasad Peri

AVP Regulatory Affairs Connected Delivery, Devices and Digital Health, Eli Lilly
Prasad Peri

Experienced People and Project Manager with a demonstrated history of working in the regulated pharmaceutical industry and the FDA in the CMC and Combination Product arena.

Ravi Kaushik

Vice President, Global Head of Device & Digital Innovation & Prod Strategy, Plasma Derived Therapies, Takeda Pharmaceuticals
Ravi Kaushik

Ravi joined Takeda in 2021 and is currently Vice President, Global Head of Device & Digital Innovation & Product Strategy for Plasma Derived Therapies at Takeda. He leads a cross-functional R&D team focused on developing drug delivery devices, diagnostics, and digital health products to create a global ecosystem of care for plasma therapy patients.

Sriram Natarjaan

Sr. Manager, Product Quality Management, Johnson & Johnson
Sriram Natarjaan

Sriram Natarajan Ph.D., is a Sr. Manager at Johnson & Johnson Innovative Medicine. He leads E2E Quality/Compliance and Risk Management for the Combination Product, Device & Emerging Technology portfolio with NPD and LCM projects, working collaboratively with key business partners across multiple departments and sites. Prior to this, he worked in Medical Devices and Diagnostics areas. Sriram holds a Ph.D. in Chemical Engineering from the University of Utah, with a focus on materials, devices, biomolecular interactions and computational modeling.. He was the recipient of an NSF Graduate Fellowship Award and has 16 patents granted and filed.

Yvette Appleby

Senior Manager, Digital Health & PMO, Pfizer
Yvette Appleby

Yvette Appleby, RAC, CSM, CAPM, CSPO, is a seasoned professional with a robust background in regulatory affairs and project management focused on software as a medical device. She holds a master’s degree in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University. Currently, she serves as a Senior Manager at Pfizer, where she manages the assessment process for all medical software designed, developed, or promoted by or on behalf of Pfizer. In her role, Yvette also supports business strategy and solution delivery initiatives. Yvette is also a certified Scrum Master and Product Owner.

sponsors

Conference agenda

clock

8:00

Registration & Coffee

clock

9:00

Chair's Opening Remarks

Paul Upham, Global Head of Smart Devices, Roche-Genentech

clock

9:10

Opening Address: Future Proofing Your Injectable Device Portfolios

  • Outlining key considerations for the evolving ecosystem for injectable devices including, diagnostics, SaMD and digital therapeutics
  • Exploring the global regulatory landscape evolutions for combination product reporting and recommendations
  • Best practices for ensuring safety and quality, and taking a risk-based approach
  • Khaudeja Bano, Vice President - Global Head of Device Quality, Roche-Genentech

    clock

    9:50

    Developing Phase Appropriate Requirements for Combination Products

  • Understanding the impact of performance claims vs convenience features
  • Phase appropriate design control considerations throughout the lifecycle
  • User needs commensurate with lifecycle phase
  • Opportunities to leverage industry knowledge and experience
  • Anjana Wills, Head of Device Combination Products and Software Quality, AstraZeneca

    Michael Price, Associate Director, Human Factors, AstraZeneca

    clock

    10:30

    Morning Coffee

    clock

    11:00

    Overview of a Device Connected Submission

    Mark Harycki, Senior Director, Device Portfolio and Program Management, Eli Lilly and Company

  • Background: Overview of the medical device development process, focusing on mechanical and electronic integration
  • Key to success: Collaborating with suppliers for seamless integration through clear communication, early expectation setting, and adherence to quality and timelines
  • Platform strategies: Optimizing and streamlining future device-connected submissions and commercial supply for efficiency and scalability
  • clock

    11:40

    Health Patches -from Development to Upscaled Manufacturing

    Dan Jeffrey, Director of Sales - Medical, Lohmann Corporation

  • Wearables – From Development to Manufacturing
  • Early stage considerations for skin bonding
  • Critical factors for the design of wearables in relation to skin bonding
  • Value of vertically integrated supply in skin adhesive (patch)
  • Potential for ‘Smart Patch’ in wearable design
  •  

    clock

    12:20

    Networking Lunch

    clock

    13:20

    Advancing Subcutaneous Delivery: A High Viscosity and High-Volume Platform Technology Approach

    Cindy Tritton

    Cindy Tritton, Project Lead, Senior Engineer III, Technical Development , Biogen

  • Examine design strategies and considerations to enable efficient delivery of high-volume, high-viscosity drugs through subcutaneous administration
  • Assess patient tolerance and user acceptability of high-volume injectables, focusing on improving comfort and adherence
  • Provide an overview of current challenges faced by wearable devices in delivering larger volumes and strategies to optimize subcutaneous delivery systems for enhanced patient experience
  • Discuss emerging trends and innovations shaping the future of high-volume subcutaneous drug delivery
  • clock

    14:00

    Key Performance and Quality Considerations for Wearable Injector Development

    Sriram Natarjaan, Sr. Manager, Product Quality Management, Johnson & Johnson

  • Overview of the latest applicable standards and regulations impacting wearable injector development
  • Insights into design verification challenges and learnings to implement
  • High-viscosity formulation challenges
  • Human Factors and User preferences
  • clock

    14:40

    Afternoon Networking Break

    clock

    15:10

    Design Space Considerations and Early-Stage Performance Testing for Combination Products

    George Currier, Senior Principal Scientist, Device Development, Bristol Myers Squibb

  • Understanding the design space and its potential variations for device evaluation and selection
  • Applying early-stage performance testing to rapidly gather insights with a limited quantity of devices
  • Leveraging learnings to promote focused and productive early engagement during a development program
  • clock

    15:50

    Optimising Formulation for High Concentration, High Volume Drug Development and Delivery

    Deep Bhattacharya, Principal Scientist Formulation and Process Development - Biotherapeutics, Pfizer

  • Examining current paradigms in subcutaneous drug delivery for these products
  • Applying a biophysical perspective to drug development
  • Navigating formulation challenges and opportunities in high concentration subcutaneous injection, highlighting key focus areas
  • clock

    16:30

    Chair’s Closing Remarks and Close of Day One

    Paul Upham, Global Head of Smart Devices, Roche-Genentech

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chair's Opening Remarks

    Paul Upham, Global Head of Smart Devices, Roche-Genentech

    clock

    9:10

    Understanding the Sustainability Impacts of Connected Devices and Wearable Injectors

    Paul Upham, Global Head of Smart Devices, Roche-Genentech

  • Analysing the environmental footprint of connected devices and wearable injectors, focusing on materials, manufacturing processes, and end-of-life considerations
  • Exploring opportunities to reduce waste through sustainable design and recycling initiatives in the production of drug delivery devices
  • Reviewing the impact of connected devices in promoting sustainability through data collection, remote monitoring, and optimising patient outcomes while reducing healthcare system burdens
  • Addressing regulatory challenges and industry efforts to align wearable injectors with global sustainability goals and environmentally responsible practices
  • clock

    9:50

    Innovations in On-Body Injector Development: Lessons from Two Large Volume Delivery Device Case Studies

    Harry Jiang, Device Engineering Lead, Alexion Pharmaceuticals

  • Outlining design strategies for on-body injectors with insights from two projects, including challenges, user-centric design, and integration with drug formulation and primary packaging
  • Delving into lessons learned in adhesive performance and user interface development from the programs
  • Key hurdles in gaining regulatory approval, and scaling manufacturing for market launch
  • clock

    10:30

    Morning Coffee

    clock

    11:10

    PANEL DISCUSSION: Digital Health from Clinic to Commercialization: Navigating the steps to success

  • Leveraging digital solutions to personalize patient experiences, improve adherence, and increase retention, all for better outcomes
  • Navigating regulatory and market access challenges: key considerations for compliance, reimbursement strategies, and aligning digital health with evolving regulatory landscapes
  • Best practices for ensuring a seamless transition from clinical development to market launch, maximizing adoption, and demonstrating value to stakeholders
  • Paul Upham, Global Head of Smart Devices, Roche-Genentech

    Mark Harycki, Senior Director, Device Portfolio and Program Management, Eli Lilly and Company

    Ravi Kaushik, Vice President, Global Head of Device & Digital Innovation & Prod Strategy, Plasma Derived Therapies, Takeda Pharmaceuticals

    Jia Huang, Associate Director, Merck & Co.

    Prasad Peri, AVP Regulatory Affairs Connected Delivery, Devices and Digital Health, Eli Lilly

    clock

    12:10

    Networking Lunch

    clock

    13:20

    Lifecyle Management: Collaboration with External Providers

    Ellie Younger, Global Technical Operations, AstraZeneca

  • External partnerships such as supplier and contract manufacturing relations can present complex challenges
  • Combination product developers often rely on external suppliers for procuring components, subassemblies and/or performing assembly and packaging manufacturing operations
  • This presentation will discuss some common scenarios encountered during the lifecycle management of a combination product and propose strategies for successful resolution of quality events
     
  • clock

    14:00

    Integrating SaMD in Patient-Centric Digital Health

    Yvette Appleby, Senior Manager, Digital Health & PMO, Pfizer

  • Overview of the role of Software as a Medical Device (SaMD) in advancing digital health solutions
  • Highlighting the importance of digital health literacy in empowering patients to understand and utilize their healthcare data
  • Examining the application of data from both patient and care provider perspectives, focusing on enhancing care delivery and outcomes
  • Address barriers and enablers for the adoption of digital health tools, emphasizing strategies to foster patient and provider engagement
  • clock

    14:40

    Afternoon Tea

    clock

    15:10

    Advancing Digital Diagnostics as Medical Devices - From Modality to Implementation

    Cheng Yang, Digital Diagnostics Lead, Drug Product and Device Development, R&D, Takeda

  • Exploring how digital diagnostics enhance the functionality of medical devices, enabling real-time monitoring and improved patient outcomes
  • Insight into innovations in digital diagnostic and medical device integration, focusing on seamless data exchange and user-centric design
  • Future Trends in Digital Health: Highlight emerging technologies and strategies shaping the future of digital diagnostics, emphasizing their role in transforming healthcare delivery
  • clock

    15:50

    Chair’s Closing Remarks and Close of Day Two

    Paul Upham, Global Head of Smart Devices, Roche-Genentech


    Head of Device Combination Products and Software Quality
    AstraZeneca
    Digital Diagnostics Lead, Drug Product and Device Development, R&D
    Takeda
    Project Lead, Senior Engineer III, Technical Development
    Biogen
    Director of Sales - Medical
    Lohmann Corporation
    Principal Scientist Formulation and Process Development - Biotherapeutics
    Pfizer
    Global Technical Operations
    AstraZeneca
    Senior Principal Scientist, Device Development
    Bristol Myers Squibb
    Device Engineering Lead
    Alexion Pharmaceuticals
    Associate Director
    Merck & Co.
    Vice President - Global Head of Device Quality
    Roche-Genentech
    Senior Director, Device Portfolio and Program Management
    Eli Lilly and Company
    Associate Director, Human Factors
    AstraZeneca
    Global Head of Smart Devices
    Roche-Genentech
    AVP Regulatory Affairs Connected Delivery, Devices and Digital Health
    Eli Lilly
    Vice President, Global Head of Device & Digital Innovation & Prod Strategy, Plasma Derived Therapies
    Takeda Pharmaceuticals
    Sr. Manager, Product Quality Management
    Johnson & Johnson
    Senior Manager, Digital Health & PMO
    Pfizer

    Gold Sponsor

    Exhibitors

    Official Media Partner

    VENUE

    Courtyard by Marriott Boston Downtown

    Boston, USA

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing SMi Group Trading As SAE Media Group. SMi Group Trading As SAE Media Group books all hotel rooms directly. If you are approached by a third-party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third-party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Current Attendee List

    Download

    Sponsor Prospectus

    Download

    Past Speaker Interview: Paul Upham

    Download

    Past Speaker Interview: Alexandra Benbadis

    Download

    Chair Letter: Paul Upham

    Download

    Past Presentation - Martin McLoughlin

    Download

    Past Presentation - Karen Lowitz

    Download

    Past Presentation - Ajit D’Souza

    Download

    Sponsors and Exhibitors


    Lohmann

    Gold Sponsor
    https://www.lohmann-tapes.us/us/site__264/?

    Lohmann is a privately held company headquartered in Neuwied Germany. We are a pressure sensitive adhesive manufacturer and converter, specializing in component parts for wearable, ostomy, diagnostic and other medical related applications. With both US and EU manufacturing sites, we are a leading provider of adhesive and value chain solutions for the Medical Device Industry. We engineer our adhesives and technologies into usable forms that enhance our customer’s product performance, production efficiency and sustainability.


    Exhibitors


    TxSphere

    Exhibitors
    http://www.tx2sphere.com

    TxSphere was founded as a spin-off of Intuvie LLC to focus exclusively on drug delivery devices for drug-device combination products. This new company builds on our experience with infusion pumps, connectivity, and a custom drug delivery device for a pharmaceutical combination product. Our first product is the Horizon, a unique semi-reusable micro wearable injector platform. The Horizon system is a pod-sized device that is capable of larger infusion volumes up to 20 mL or more. The latest version, the Horizon III, is reusable and rechargeable. The disposable component includes a micro cannula insertion system and can be pre-filled with medication. For more information, please see www.tx2sphere.com.


    Media Partners


    Drug Development and Delivery

    Official Media Partner
    http://drug-dev.com/

    Drug Development & Delivery, including its exclusive Specialty Pharma section, is a print publication, conference organizer (Drug Development Networking Summit), and online content provider exclusively committed to advancing the applied science, technology, and related business practices of pharmaceutical and biological drug development, reporting on formulation design, bioavailability and solubility enhancement, drug delivery and platform technologies, life cycle management, compound-enabling strategies, business development, outsourcing services, and partnerships and collaborations. Through insightful scientific, business, news, and technology-related formats, Drug Development & Delivery provides pharmaceutical professionals with practical solutions to the issues, opportunities, and challenges in the ever-evolving drug development communities. We complement your business development initiatives, connecting you with and influencing the audiences that matter most to you: investors, business partners, technology and service seekers, and regulatory agencies.


    ONdrugDelivery

    Official Media Partner
    http://ondrugdelivery.com

    ONdrugDelivery provides readers throughout global pharma/biopharma with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: ondrugdelivery.com/subscribe


    pharmaphorum

    Official Media Partner
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    Pharma Journalist

    Official Media Partner
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    The Medicine Maker

    Official Media Partner
    https://themedicinemaker.com/?utm_source=media_partner_24&utm_medium=event&utm_campaign=sae_media_logo

    The Medicine Maker is a print and digital publication as well as a weekly newsletter. At The Medicine Maker, we bring people into the limelight, showcasing the industry’s success stories and examining its biggest points of contention. Engaging content covers the entire spectrum of drug development, keeping all medicine makers up to date with the most pressing topics, trends and technologies driving the pharma industry forward. Register for your FREE print or digital magazine or subscribe to our newsletter here! https://themedicinemaker.com/?utm_source=media_partner_24&utm_medium=event&utm_campaign=sae_media_logo

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Courtyard by Marriott Boston Downtown


    USA

    Courtyard by Marriott Boston Downtown

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.

    Join the loitering munitions community

    Keep up to date with industry news, insights, and community updates FREE and direct to your inbox every month!
    * - required fields
    You can unsubscribe at any time. For full details see our Privacy Policy